PDE/ADE + OEL + OEB Reports

PDE – OEL Report | Regulatory Services

Available Substance Database

We maintain comprehensive reports on the following substances. Select any to view detailed assessment information:

0 substances selected

Request a PDE/OEL Report

Fill out the form below to request a custom assessment for your substances. Our team will contact you within 24 hours.

    No substances selected.

    Frequently Asked Questions

    PDE/ADE, OEL, and OEB reports are toxicological assessments used to support safe occupational exposure and handling of pharmaceutical substances. They help organizations understand acceptable exposure levels and apply appropriate controls when working with potentially hazardous compounds.

    A Permitted Daily Exposure (PDE) or Acceptable Daily Exposure (ADE) assessment determines the amount of a substance that a person can be exposed to daily without appreciable health risk. The assessment is based on available toxicological and pharmacological evidence.

    An OEL defines an acceptable concentration of a substance in the workplace air over a specified exposure period. It helps organizations establish appropriate controls for employees involved in manufacturing, handling, sampling, testing, or other activities involving pharmaceutical substances.

    An OEB is a classification approach used to group substances according to their potential health hazards and occupational exposure requirements. It can help organizations determine suitable containment, engineering controls, personal protective equipment, and handling practices.

    These assessments provide a scientific basis for managing occupational and cross-contamination risks. They can support facility design, containment strategies, cleaning considerations, worker protection, and safe handling of pharmaceutical substances.

    A PDE/ADE assessment considers relevant available information about the substance, including toxicological and pharmacological data. The assessment uses the available scientific evidence to establish an appropriate exposure value and document the rationale behind it.

    PDE/ADE generally focuses on a safe systemic daily exposure, while OEL focuses on workplace exposure, commonly through inhalation. The two assessments address related but different aspects of occupational and pharmaceutical safety.

    When sufficient data are not available to establish a definitive numerical OEL, an OEB approach can provide a structured way to categorize the substance’s hazard potential. This can help organizations implement appropriate exposure-control measures.

    The available database contains a broad range of pharmaceutical substances, active ingredients, chemicals, biological products, extracts, and other substances. Examples include Abacavir, Abemaciclib, Acetaminophen, Acalabrutinib, Adalimumab, Amoxicillin, Aspirin, Atorvastatin, Azithromycin, and many others.

    Yes. The database includes pharmaceutical active ingredients as well as various chemicals, excipients, solvents, natural extracts, and other substances. The listings range from medicines such as Ibuprofen and Insulin to chemicals and materials such as Hydrochloric Acid, Hydrogen Peroxide, and Hydroxyethyl Cellulose.

    Yes. The database is designed to allow users to select a substance and view the available assessment information. The extensive listing includes substances across the alphabet, from early entries such as 1,3-Butanediol through numerous pharmaceutical and chemical substances.

    Yes. The database includes a number of biological and biotechnology-related substances, including Adalimumab, Aflibercept, Bevacizumab, Eculizumab, Etanercept, Insulin Aspart, Insulin Glargine, and Interferons.

    Yes. The database contains substances used across pharmaceutical and animal-health applications. Examples include Afoxolaner, Amprolium, Cefovecin, Cefquinome, Danofloxacin, Doramectin, Enrofloxacin, and Eprinomectin.

    Yes. PDE/ADE, OEL, and OEB assessments can provide useful scientific input for pharmaceutical manufacturing activities where substance exposure and containment need to be evaluated. They can help organizations make informed decisions about handling and occupational risk controls.

    They can provide important exposure-limit information for evaluating potential cross-contamination and containment risks. The resulting values or classifications can be considered alongside manufacturing processes, facility design, equipment, and existing control measures.

    Substances with potent pharmacological activity, toxicological hazards, or significant occupational exposure concerns may require detailed assessment. The database reflects a wide range of substances, including highly active pharmaceutical ingredients, chemicals, and other materials with different hazard profiles.

    Yes. These assessments can complement one another when developing an overall occupational and pharmaceutical safety strategy. PDE/ADE provides a daily exposure perspective, while OEL and OEB help address workplace exposure and hazard-control requirements.

    The assessment outcomes can be used as scientific inputs for occupational health, industrial hygiene, containment, facility, and manufacturing risk-management activities. They can also help organizations establish appropriate handling and exposure-control strategies for individual substances.

    Yes. The database contains substances spanning numerous therapeutic and chemical categories, including antibiotics, oncology products, hormones, biologics, cardiovascular medicines, solvents, acids, natural extracts, and other materials.

    Masuu Global can support organizations requiring scientific and toxicological assessment of pharmaceutical substances for occupational exposure and risk-management purposes. Our expertise can help clients obtain appropriate PDE/ADE, OEL, and OEB assessments and use the resulting information to support compliant and scientifically sound safety strategies.

    Book a Demo